Co-founder, Chief Innovation and Strategy Officer at Vaccibody AS.

Joined February 2010
20 Photos and videos
Joining forces with >60 leaders in immunology to encourage FDA to increase the focus on T cell responses in COVID-19 and infectious diseases in general.
Here is the full text of the letter to the FDA about T cell responses in COVID vaccine studies.
12
We select our partners carefully! Enjoy the collaboration with the competent team at Adaptive Biotechnologies generating 3rd generations vaccines. Listen to the webcast at 4 pm today. bit.ly/36uEsEl

3
11
This is an amazing achievement by the entire Vaccibody family! Thanks to the patients, investigators, collaborators and all Vaccibody team members for the dedication to this important study. vaccibody.com/wp-content/upl…

2
2
30
Proud and excited for reaching this milestone! Rewarding to work with JZ and the rest of the Nektar team.
We are excited to announce we reached an important milestone in our partnership with Vaccibody, dosing the first patient in our Phase 1/2a study arm evaluating the combination of bempeg with VB10.NEO. Read more: bit.ly/3afAVei
1
3
15
Very excited about the strong signs of vaccine-induces clinical responses, backed up with a range of scientificly sound correlations, in our cancer neoantigen vaccine trial! lnkd.in/eP4csKp #cancerresearch #cancervaccine #neoantigens

3
6
22
Thanks for the invite and opportunity to share my journey. Really enjoyed the entire program and the interactive discussions!
Last fireside chat before our Panel! Wonderful to have @Vaccibody President & CSO Agnete Fredriksen sharing with us - “How to manage the #science of a #biotech company”!
2
2
13
Agnete B. Fredriksen retweeted
🎤 Speaker #1 - We're thrilled to have Agnete Fredriksen @ABFredriksen, CSO of @Vaccibody, join us at Labiotech Insider Day! Take a sneak peek at the program & register today! 👉🏻 bit.ly/2KHPWLe 👈🏻 #biotech #LBRefresh
5
8
Agnete B. Fredriksen retweeted
24 Oct 2018
NRK EKKO har laget et flott radioinnslag om vår porteføljebedrift Vaccibody der @ABFredriksen forteller om hvordan de utvikler persontilpassede kreftvaksiner: radio.nrk.no/serie/ekko#t=58… #helsenæring #kreft
7
10
Finansavisen lørdag- hvorfor er Vaccibody og Nektar så gode partnere?
5
13
Agnete B. Fredriksen retweeted
We’ve entered into a new clinical collaboration with Vaccibody to combine their personalized neo-antigen cancer vaccine with NKTR-214. Learn more about this combination's design to harness specific T cell clonal expansion in the fight against cancer: bit.ly/2xqtkr6
4
13
Trying to convince our Minister of Trade and Industry to create better incentiver for startup and founders:-) #timeforchange #startup #politicians
1
13
Agnete B. Fredriksen retweeted
18 Apr 2018
Ny pod er ute nå. @elikirand har besøk av @ABFredriksen og Martin Bonde fra vår porteføljebedrift #Vaccibody: Vi snakker om utviklingen av deres persontilpassede kreftvaksine og planer for framtiden soundcloud.com/user-97220871…
7
13
Agnete B. Fredriksen retweeted
11 Apr 2018
– Vi skreddersyr kreftvaksiner til hver pasient. Vi tar immunterapi ett skritt videre, og bruker kunnskapen til å utvikle enda mer persontilpasset medisin, sier president og grunnlegger av #Vaccibody, @ABFredriksen, til VG. vg.no/i/6nKj0L
4
16
Read about our unique personalized cancer therapy in today news
3
18